Literature DB >> 23512381

Referral patterns for patients with high-risk thyroid cancer.

Megan R Haymart1, Mousumi Banerjee, Di Yang, Andrew K Stewart, Jennifer J Griggs, James C Sisson, Ronald J Koenig.   

Abstract

OBJECTIVE: Knowledge of referral patterns for specialty cancer care is sparse. Information on both the need and reasons for referral of high-risk, well-differentiated thyroid cancer patients should provide a foundation for eliminating obstacles to appropriate patient referrals and improving patient care.
METHODS: We surveyed 370 endocrinologists involved in thyroid cancer management. From information in a clinical vignette, respondents were asked to identify the reasons they would need to refer a high-risk patient to a more specialized facility for care. We performed multivariable analysis controlling for hospital and physician characteristics.
RESULTS: Thirty-two percent of respondents reported never referring thyroid cancer patients to another facility. Of those that would refer a high-risk patient to another facility, the opportunity for a patient to enter a clinical trial was the most common reason reported (44%), followed by high-dose radioactive iodine (RAI) with or without dosimetry (33%), lateral neck dissection (24%), and external beam radiation (15%). In multivariable analysis, endocrinologists with a higher percentage of their practice devoted to thyroid cancer care were significantly less likely to refer patients to another facility (P = .003).
CONCLUSION: The majority of endocrinologists treating thyroid cancer patients report referring a high-risk patient to another facility for some or all of their care. Knowledge of the patterns of physician referrals and the likelihood of need for referral are key to understanding discrepancies in referral rates and obstacles in the referral process.

Entities:  

Mesh:

Year:  2013        PMID: 23512381      PMCID: PMC3747229          DOI: 10.4158/EP12288.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  24 in total

1.  Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.

Authors:  R Michael Tuttle; Rebecca Leboeuf; Richard J Robbins; Rebecca Qualey; Keith Pentlow; Steven M Larson; Chee Y Chan
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

2.  Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.

Authors:  Robert Dorn; Juergen Kopp; Harry Vogt; Peter Heidenreich; Robert G Carroll; Seza A Gulec
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

3.  Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction.

Authors:  Amy K Alderman; Sarah T Hawley; Jennifer Waljee; Monica Morrow; Steven J Katz
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

4.  Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.

Authors:  Sin-Ming Chow; Stephen Yau; Chung-Kong Kwan; Patricia C M Poon; Stephen C K Law
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

5.  Referral bias in thyroid cancer surgery: direction and magnitude.

Authors:  A Machens; S Hauptmann; H Dralle
Journal:  Eur J Surg Oncol       Date:  2007-08-23       Impact factor: 4.424

6.  Utilization of total thyroidectomy for papillary thyroid cancer in the United States.

Authors:  Karl Y Bilimoria; David J Bentrem; John G Linn; Andrew Freel; Jen Jen Yeh; Andrew K Stewart; David P Winchester; Clifford Y Ko; Mark S Talamonti; Cord Sturgeon
Journal:  Surgery       Date:  2007-11-05       Impact factor: 3.982

7.  The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.

Authors:  J A Sosa; H M Bowman; J M Tielsch; N R Powe; T A Gordon; R Udelsman
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

8.  The relationship between extent of thyroid cancer surgery and use of radioactive iodine.

Authors:  Megan R Haymart; Mousumi Banerjee; Di Yang; Andrew K Stewart; Gerard M Doherty; Ronald J Koenig; Jennifer J Griggs
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

9.  Surgeon volume and operative mortality in the United States.

Authors:  John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

Review 10.  Measuring surgical quality: what's the role of provider volume?

Authors:  Justin B Dimick; John D Birkmeyer; Gilbert R Upchurch
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

View more
  7 in total

1.  REFERRAL OF OLDER THYROID CANCER PATIENTS TO A HIGH-VOLUME SURGEON: RESULTS OF A MULTIDISCIPLINARY PHYSICIAN SURVEY.

Authors:  Maria Papaleontiou; Paul G Gauger; Megan R Haymart
Journal:  Endocr Pract       Date:  2017-05-23       Impact factor: 3.443

2.  Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013).

Authors:  Stacey A Fedewa; Ahmedin Jemal; Amy Y Chen
Journal:  Eur Thyroid J       Date:  2016-10-21

3.  Population-Based Assessment of Complications Following Surgery for Thyroid Cancer.

Authors:  Maria Papaleontiou; David T Hughes; Cui Guo; Mousumi Banerjee; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

4.  Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities.

Authors:  Archana Radhakrishnan; David Reyes-Gastelum; Paul Abrahamse; Brittany Gay; Sarah T Hawley; Lauren P Wallner; Debbie W Chen; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 6.134

5.  Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US.

Authors:  Sylvie Stacy; Omar Hyder; David Cosgrove; Joseph M Herman; Ihab Kamel; Jean-Francois H Geschwind; Ahmet Gurakar; Robert Anders; Andrew Cameron; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-06-19       Impact factor: 3.452

6.  Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey.

Authors:  David T Hughes; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Megan R Haymart
Journal:  Ann Surg       Date:  2020-10-16       Impact factor: 13.787

7.  Physician management of thyroid cancer patients' worry.

Authors:  Maria Papaleontiou; Bradley Zebrack; David Reyes-Gastelum; Andrew J Rosko; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  J Cancer Surviv       Date:  2020-09-16       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.